Probably Genetic

📍 San Francisco, United States👥 12 employees💰 Last funded Mar 2018
Biotechnology Research🌐 probablygenetic.com
Website LinkedIn
Probably Genetic helps undiagnosed rare disease patients find answers to their symptoms in a matter of weeks. There are over 400 million people worldwide that have a rare disease — more than cancer and HIV patients combined. Half of those patients are currently undiagnosed and half of them are children, and it takes 5-7 years on average for these patients to get a diagnosis. With our system, patients can get answers in a matter of weeks. Our online Symptom Checker identifies rare disease patients using state-of-the-art machine learning models, gets them tested through our direct-to-consumer genetic testing service, and helps connect these patients to potentially life-saving treatments and advocacy communities. We partner with drug developers to offer sponsored testing programs that allow patients to access genetic testing for little to no cost.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
1
Frequently asked questions
Who invested in Probably Genetic?
Probably Genetic has 1 investors on record on gritt.io.
When did Probably Genetic last raise funding?
The most recent investment in Probably Genetic recorded on gritt.io was in March 2018.
What industry is Probably Genetic in?
Probably Genetic operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Probably Genetic based?
Probably Genetic is headquartered in San Francisco, United States.